Las Vegas, NV -- (SBWIRE) -- 12/02/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Hercules Offshore, Inc. (NASDAQ:HERO), XOMA Corp (NASDAQ:XOMA), Pharmaceuticals Inc (NASDAQ:AVNR), Stillwater Mining Company (NYSE:SWC)
Hercules Offshore, Inc. (NASDAQ:HERO) managed to keep its gain at 0.79% on below -normal volume of 905,349.00 shares. The stock settled at $6.39 after floating in a range of $6.29 to $6.40. Its latest price has reached market capitalization of $1.02 billion. Its 52-week range has been $5.04 to $7.96. Hercules Offshore, Inc. (Hercules Offshore) provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry globally. It provides these services to national oil and gas companies, integrated energy companies and independent oil and natural gas operators. As of February 23, 2012, it owned a fleet of 42 jackup rigs, 17 barge rigs, two submersible rigs, one platform rig, 58 liftboat vessels and operate an additional five liftboat vessels owned by a third party.
For How Long HERO will fight for Profitability? Read This Trend Analysis report
XOMA Corp (NASDAQ:XOMA) traded up on a volume of 896,205.00, lower than its standard daily volume. Shares have gained 3.46% to $4.78. Over the last twelve months, the stock has gained 315.65% and faced a worst price of $2.37. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
For How Long XOMA’s Gloss will Attract Investors? Find out via this report
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) settled 1.37% higher at $4.44 on below -normal volume of 888,749.00 shares during the last trading day. The stock has its 12-month high at $6 and 52-week low price was $2.34. It traded in a range of $4.38 to $4.50 during the last trading day. AVANIR Pharmaceuticals, Inc. (AVANIR) is a pharmaceutical company focused on developing and commercializing therapeutic products for the treatment of central nervous system disorders. The Company focuses on products for the central nervous system. It also has a number of partnered programs in other therapeutic areas.
Why Should Investors Buy AVNR After the Recent Fall? Just Go Here and Find Out
In the last trading session, Stillwater Mining Company (NYSE:SWC) was up on low volume, trading at a volume of 885,563.00 shares versus its average daily volume of 1.08 million shares. At $11.23, the stock has attained market capitalization of $1.34 billion. Stillwater Mining Company is engaged in the development, extraction, processing, smelting, refining and marketing of palladium, platinum and associated metals (platinum group metals (PGMs)) from a geological formation in south-central Montana, the J-M Reef, and from the recycling of spent catalytic converters.
Will SWC Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)